BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
Input momentum (manajer yang sebanding):
keluasan pemegang +4.3% ·
aliran saham +1.6% ·
posisi baru bersih +4.2%
· formula
Akumulasi luas: saham yang meningkat di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +1 | 1.32B | $76.14B | +6 | −6 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | n/a |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | n/a | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | n/a | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | n/a |
| Q2 2024 | 19 | n/a | 159.17M | $6.60B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 194.93M | n/a | $9.02B | 0.1% | n/c | 1 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (pasif) | 172.23M | n/a | $7.97B | 0.2% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (pasif) | 94.74M | -0.1% | $4.39B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 46.18M | +1.6% | $2.13B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (pasif) | 33.57M | +0.6% | $1.55B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 25.82M | +8.8% | $1.20B | 0.2% | ▲ Add | 5 | SEC ↗ ×7 |
| 7 | PRIMECAP Management ✦ | 22.94M | -0.1% | $1.06B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 16.23M | n/a | $751.20M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 9 | Arrowstreet Capital ✦ | 11.31M | +428.5% | $523.60M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 10 | Dodge & Cox ✦ | 8.44M | -35.2% | $390.54M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 7.27M | +25.6% | $336.70M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 12 | AQR Capital Management ✦ | 6.07M | +1.7% | $280.67M | 0.2% | ▲ Add | 5 | SEC ↗ ×7 |
| 13 | Renaissance Technologies ✦ | 3.48M | +67.8% | $161.14M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 2.70M | +15.5% | $125.16M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 914.14K | +182.9% | $40.68M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 16 | Two Sigma Investments ✦ | 864.76K | +203.9% | $40.03M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 607.99K | +104.7% | $28.14M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 518.22K | -31.7% | $23.99M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 19 | Millennium Management ✦ | 264.35K | -52.3% | $12.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 226.98K | +2.8% | $10.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 195.96K | -90.0% | $9.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | GAMCO Investors ✦ | 102.10K | +2.8% | $4.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Tweedy, Browne ✦ | 7.18K | Baru | $332,547 | 0.0% | New | 1 | SEC ↗ |
| 24 | Marshall Wace ✦ | 4.76K | Baru | $220,572 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tweedy, Browne | $332,547 | 0.0% |
| Marshall Wace | $220,572 | 0.0% |
Telah keluar
| Harris Associates (Oakmark) | $731,880 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 6.60K saham, $400 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 6.25K lbr · $403,498
Officer · 500 lbr · $33,750
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi